Last quarter (Q ), CURE Pharmaceutical Holding's total revenue was $1.24M, an increase of 12.24% from the same quarter last year. In Q, CURE Pharmaceutical Holding's net income was $-209.00K. See CURE Pharmaceutical Holding’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 5.03M	$ 4.90M	$ 6.55M	$ 2.05M	$ 623.00K	$ 584.00K
Cost of Revenue	$ 1.47M	$ 1.56M	$ -2.17M	$ 1.08M	$ 231.00K	$ 280.00K
Gross Profit	$ 3.57M	$ 3.34M	$ 4.38M	$ 975.00K	$ 392.00K	$ 304.00K
Operating Expense	$ 18.75M	$ 21.61M	$ -19.47M	$ 14.15M	$ 12.43M	$ 7.86M
Operating Income	$ -6.82M	$ -8.96M	$ -17.53M	$ -13.18M	$ -12.04M	$ -7.56M
Net Non Operating Interest Income Expense	$ -282.00K	$ -465.00K	$ -554.00K	$ -2.44M	$ -4.05M	$ -3.04M
Other Income Expense	$ -2.78M	$ 6.22M	$ 43.00K	$ -15.01M	$ -5.28M	$ 164.00K
Pretax Income	$ -10.87M	$ -18.50M	$ -13.19M	$ -30.62M	$ -21.37M	$ -10.43M
Tax Provision	$ 42.00K	$ 42.00K	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -20.57M	$ -25.51M	$ -18.06M	$ -30.62M	$ -21.36M	$ -10.40M
Basic EPS	$ -0.30	$ -0.36	$ -0.26	$ -0.65	$ -0.62	$ -0.42
Diluted EPS	$ -0.30	$ -0.36	$ -0.26	$ -0.65	$ -0.62	$ -0.42
Basic Average Shares	$ 70.98M	$ 1.11M	$ 50.18M	$ 47.31M	$ 34.54M	$ 25.00M
Diluted Average Shares	$ 70.98M	$ 1.11M	$ 50.18M	$ 47.31M	$ 34.54M	$ 25.00M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 20.21M	$ 23.17M	$ -21.65M	$ 15.23M	$ 12.66M	$ 8.14M
Net Income From Continuing And Discontinued Operation	$ -20.57M	$ -25.51M	$ -18.06M	$ -30.62M	$ -21.36M	$ -10.40M
Normalized Income	$ 14.58M	$ -3.65M	-	$ -24.93M	$ -16.65M	$ -10.17M
Interest Expense	$ 191.00K	-	-	$ 2.47M	$ 4.11M	$ 3.04M
EBIT	$ -10.59M	$ -18.03M	$ -12.64M	$ -28.15M	$ -17.26M	$ -7.39M
EBITDA	$ -9.97M	$ -16.45M	$ -16.25M	$ -27.23M	$ -16.68M	$ -7.25M

Currency in USD

CURE Pharmaceutical Holding Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing